Senti Biosciences, Inc. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Operating Expenses
Income Breakdown
Revenue
$22K
R&D↓-0.2% -$12K
$8M
D&A↓-4.7% -$44K
$893K
Operating Income↓-11.4% -$2M
$-17M
EBITDA↓-4.7% -$44K
$893K
Interest Expense↓-57.8% -$133K
$97K
Tax Provision
$0
Net Income↑+37.2% +$11M
$-18M
Operating Margin
—
Net Margin
—
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↓-11.9pts
0.0%
Operating Lease Cost↓-1.5% -$20K
$1M
Revenue YoY Variation
-100.0%
Income YoY Variation↓-76.7pts
-11.4%
Revenue QoQ Variation
—
Income QoQ Variation↑+13.0pts
-0.9%